
Natco Pharma Limited has informed the Exchange regarding a press release dated February 13, 2023, titled "NATCO files generic Olaparib Tablets in USA".
Filed with NSE ·
Watch NATCO Pharma's latest callNatco Pharma (NSE:NATCOPHARM) Q1 2026 Earnings Call · Replay · Aug 14Read the transcript of Natco Pharma (NSE:NATCOPHARM) Q1 2026 Earnings Call
Natco Pharma Limited has informed the Exchange regarding a press release dated February 13, 2023, titled "NATCO files generic Olaparib Tablets in USA".
6ix hasn’t read this filing yet.
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma